Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-26

Clinical Trial Update: Higher Doses of Botulinum Toxin in the Treatment of Gummy Smile [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating higher doses of botulinum toxin for treating gummy smile has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Peking University | Conditions: Smiling, Botulinum Toxins, Type A | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-04-26